Pharmaceuticals2026-05-15 · 8 min read

Rimadyl for Dogs: Carprofen Uses, Side Effects, and What Monitoring Actually Catches

What dog owners and veterinary teams need to know about Rimadyl (carprofen): labeled uses, the side effects that matter, breed signals, and the monitoring schedule that catches problems early.

Ran Chen
Ran Chen
Founder, VetMedGuide. Life-sciences operator and 10× global market-access lead.
Published

Carprofen — sold under the brand name Rimadyl and several generic names including Novox, Vetprofen, and Carprieve — is one of the most widely prescribed veterinary NSAIDs in the United States. It is FDA-approved for dogs only and carries two labeled indications: relief of pain and inflammation associated with osteoarthritis, and control of postoperative pain associated with soft tissue and orthopedic surgeries.

This article covers what the label actually says, which side effects matter most, why Labrador Retrievers show up disproportionately in the hepatotoxicity data, and what a monitoring plan should look like in practice.

How carprofen works

Carprofen is a non-steroidal anti-inflammatory drug that preferentially inhibits cyclooxygenase-2 (COX-2) over COX-1. COX-2 drives inflammation and pain signaling; COX-1 protects the stomach lining and supports renal blood flow. By leaning toward COX-2 inhibition, carprofen reduces GI side effects compared to older non-selective NSAIDs — but it does not eliminate them. At therapeutic doses, COX-1 inhibition is reduced but not zero, and overdoses increase COX-1 activity and the likelihood of adverse effects.

Carprofen is metabolized primarily in the liver. Metabolites are excreted largely in feces (70–80%) with a smaller fraction in urine (10–20%). Some enterohepatic circulation occurs. The elimination half-life in dogs ranges from 8 to 18 hours, which supports once-daily or twice-daily dosing.

Labeled indications

The FDA-approved label for Rimadyl covers two uses:

  • Osteoarthritis pain and inflammation. Long-term daily use for chronic OA management.
  • Postoperative pain. Short-term use after soft tissue and orthopedic procedures. The injectable formulation can be given subcutaneously approximately two hours before surgery.

Carprofen is not FDA-approved for use in cats. Cats are more sensitive to NSAID toxicosis, and carprofen should not be given to them. Veterinarians sometimes use it off-label in other species, but that use falls outside the label.

Dosing

The labeled dose is 2 mg per pound of body weight per day (4.4 mg/kg). The total daily dose may be given as:

  • 2 mg/lb once daily, or
  • 1 mg/lb twice daily (divided dose)

Tablets and chewables are available in 25 mg, 75 mg, and 100 mg strengths, all scored. An injectable formulation (50 mg/ml) is available for subcutaneous or IV use in the clinic.

Because carprofen chewable tablets are flavored, accidental ingestion of multiple tablets is a common cause of overdose. The medication should be stored in a secure container out of reach of pets.

What the side-effect data actually shows

The most frequently reported adverse effects involve the gastrointestinal system. Based on post-approval adverse drug experience reporting to the FDA CVM, the categories break down as follows:

Gastrointestinal effects (most common)

Vomiting, diarrhea, constipation, inappetence, melena (dark tarry stools), hematemesis, GI ulceration, GI bleeding, and pancreatitis. These are the effects owners are most likely to see. Mild GI signs that appear in the first few days of treatment may be transient, but persistent or worsening symptoms — especially black stools or vomit that contains blood — require stopping the drug and contacting a veterinarian immediately.

Hepatic effects

Inappetence, vomiting, jaundice, elevated liver enzymes, abnormal liver function tests, hyperbilirubinemia, and acute hepatic toxicity. The label notes that approximately one-fourth of hepatic reports were in Labrador Retrievers. This does not mean Labs are guaranteed to have problems — the Merck Veterinary Manual describes the adverse event rate as roughly 2 events per 1,000 dogs treated, comparable to other veterinary NSAIDs — but it does mean Labs warrant particular attention during monitoring.

Idiosyncratic hepatotoxicity is unpredictable and not dose-dependent. A mean onset of about 20 days after starting therapy has been reported in the literature. Most dogs recover with drug discontinuation and supportive care, but anorexia may persist for 1–3 weeks after stopping.

Renal effects

Hematuria, polyuria, polydipsia, azotemia, and acute renal failure. Patients at greatest risk for renal toxicity are those that are dehydrated, on concomitant diuretic therapy, or those with pre-existing renal, cardiovascular, or hepatic dysfunction.

Neurologic effects

Ataxia, paresis, paralysis, seizures, vestibular signs, and disorientation.

Hematologic effects

Immune-mediated hemolytic anemia, immune-mediated thrombocytopenia, and blood loss anemia.

Dermatologic effects

Pruritus, increased shedding, alopecia, hot spots, and — rarely — necrotizing panniculitis/vasculitis.

The label notes that serious adverse reactions can occur without warning and, in rare situations, result in death. This is standard NSAID class language, but it is worth taking seriously: baseline screening and regular monitoring exist specifically to catch problems before they become emergencies.

Contraindications and drug interactions

Carprofen should not be used in dogs with:

  • Known hypersensitivity to carprofen
  • Pre-existing GI ulceration
  • Pre-existing liver or kidney disease

It should not be given with other NSAIDs or corticosteroids. The label is explicit about avoiding concurrent NSAID and steroid use because of the substantially increased risk of GI ulceration and perforation. A washout period is required when switching between NSAIDs or transitioning from corticosteroids to an NSAID — the exact duration depends on the specific drugs involved and should be determined by the prescribing veterinarian.

Carprofen is highly protein-bound, which can increase the toxic effects of other highly protein-bound drugs with narrow safety margins, including anticoagulants and digoxin.

Carprofen has not been tested in pregnant or nursing dogs and is not recommended in these patients. COX-2 plays a role in reproductive function, and the safety profile during pregnancy is unknown.

The monitoring schedule that matters

The label recommends baseline bloodwork before starting long-term therapy. This should include a chemistry panel and urinalysis to screen for pre-existing liver and kidney disease. The standard monitoring protocol:

  1. Baseline panel before starting carprofen.
  2. Recheck at 2–4 weeks to catch early liver enzyme changes. The clinical field study data showed a mean 4.1-fold rise in ALT in carprofen-treated dogs versus 1.5-fold in placebo dogs, making early rechecks important for detecting hepatopathy before clinical signs appear.
  3. Every 6 months for dogs on long-term therapy. Any dog on chronic medication of any kind should have periodic blood chemistry rechecks.

If a dog shows any adverse signs at any point — decreased appetite, vomiting, diarrhea, changes in thirst or urination, jaundice, behavioral changes — bloodwork should be checked immediately and the drug should be stopped.

Carprofen vs other veterinary NSAIDs

Carprofen is one of several NSAIDs available for dogs. Others include meloxicam (Metacam), deracoxib (Deramaxx), firocoxib (Previcox), robenacoxib (Onsior), and grapiprant (Galliprant). The choice between them depends on the individual patient:

  • Grapiprant (Galliprant) targets the EP4 prostaglandin receptor rather than COX enzymes, which may offer a different safety profile for some dogs. See our Galliprant for dogs article for a detailed comparison.
  • Librela (bedinvetmab) is not an NSAID at all — it is a monoclonal antibody against NGF, given as a monthly injection, and avoids the GI, renal, and hepatic risks of the NSAID class entirely. See our Librela for dogs article for how it compares.
  • Meloxicam is a COX-2 preferential NSAID like carprofen but with a longer half-life in cats, making it one of the few NSAIDs with a feline label (in some markets). It is still used off-label in dogs as well.
  • Deracoxib and firocoxib are more COX-2 selective than carprofen, which may further reduce COX-1–mediated GI effects, but no head-to-head trial has shown a clear clinical superiority.

No NSAID is universally safer than another. The best NSAID for a particular dog is the one the veterinarian selects after reviewing that dog's organ function, drug history, and concurrent conditions — and it is the one that is monitored appropriately.

What to ask your veterinarian

If your veterinarian is prescribing carprofen, the following questions help clarify the plan:

  • What did the baseline bloodwork show? Make sure liver and kidney values were checked before starting.
  • When should I come back for the first recheck? The 2–4 week window matters for catching early liver changes.
  • What should I watch for at home? Know the warning signs: decreased appetite, vomiting, diarrhea, black stools, increased thirst or urination, jaundice, behavioral changes.
  • Is my dog on any other medication that interacts with carprofen? Steroids and other NSAIDs must be avoided.
  • What should I do if I miss a dose? Do not double up. Give the dose when you remember and adjust the schedule accordingly.
  • What is the long-term plan? For OA dogs, NSAID therapy is typically one piece of a multimodal approach that includes weight management, exercise modification, joint supplements, and potentially physical therapy or injectable therapies like Librela or Adequan.

Generic formulations

Carprofen is available as a generic from multiple manufacturers. Brand and generic names include Rimadyl (Zoetis), Novox (Vedco), Vetprofen (Vétoquinol), Carprieve, Norocarp, Levafen, and quellin. All contain the same active ingredient and require a prescription. The choice of brand versus generic is often driven by clinic preference, client cost, and tablet palatability.

Sources